Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
30 April 2025
|
N 09:55 | Clascoterone 2 changes history +13,323 [Alara E. Dagsali (2×)] | |||
|
09:55 (cur | prev) −24 Alara E. Dagsali talk contribs | ||||
N |
|
09:54 (cur | prev) +13,347 Alara E. Dagsali talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag= Alara Ece Dagsali, M.D. |genericName=Clascoterone |aOrAn=a |drugClass=androgen receptor antagonist |indicationType=treatment |indication=WINLEVI (clascoterone) cream is an androgen receptor inhibitor indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Conditi...") |